EA201790361A1 - Доставка биоактивных антиоксидантов, заключенных в нанокапсулы - Google Patents

Доставка биоактивных антиоксидантов, заключенных в нанокапсулы

Info

Publication number
EA201790361A1
EA201790361A1 EA201790361A EA201790361A EA201790361A1 EA 201790361 A1 EA201790361 A1 EA 201790361A1 EA 201790361 A EA201790361 A EA 201790361A EA 201790361 A EA201790361 A EA 201790361A EA 201790361 A1 EA201790361 A1 EA 201790361A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antioxidant
nanoparticles
bioactive
compositions
tissue
Prior art date
Application number
EA201790361A
Other languages
English (en)
Other versions
EA035620B1 (ru
Inventor
Кристина М. Сабилов
Карлос Э. Астете
Еде Бодоки
Оливиу Востинару
Овидиу Чипрьян Самойла
Елена Динте
Original Assignee
Борд Оф Сьюпервайзорз Оф Луизиана Стэйт Юниверсити Энд Эгрикалчурал Энд Мекэникал Колледж
Юлию Хацьегану Юниверсити Оф Медсин Энд Фармеси
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Борд Оф Сьюпервайзорз Оф Луизиана Стэйт Юниверсити Энд Эгрикалчурал Энд Мекэникал Колледж, Юлию Хацьегану Юниверсити Оф Медсин Энд Фармеси filed Critical Борд Оф Сьюпервайзорз Оф Луизиана Стэйт Юниверсити Энд Эгрикалчурал Энд Мекэникал Колледж
Publication of EA201790361A1 publication Critical patent/EA201790361A1/ru
Publication of EA035620B1 publication Critical patent/EA035620B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Раскрыты способы и композиции для доставки лютеина или другого антиоксиданта в биоактивной форме к целевым тканям, таким как ткани глаза, и одновременно защищающие антиоксидант от деградации. Антиоксидант заключен в наночастицы, содержащие белок, такой как зеин, или полимер, такой как сополимер молочной и гликолевой кислот (PLGA). Предпочтительно наночастицы также связаны с поверхностно-активным веществом, обеспечивающим дополнительную защиту антиоксиданта. После введения наночастиц в целевую ткань биоактивный антиоксидант высвобождается в ткань в течение определенного периода времени. Наночастицы необязательно смешивают с термочувствительным биоадгезивным гелем, способствующим медленному высвобождению антиоксиданта. Указанные способы и композиции применимы для лечения или профилактики таких состояний, как возрастная дегенерация желтого пятна или катаракты.
EA201790361A 2014-08-11 2015-08-10 Способы и композиция для лечения или профилактики катаракты EA035620B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462035683P 2014-08-11 2014-08-11
US201562172455P 2015-06-08 2015-06-08
PCT/US2015/044483 WO2016025394A2 (en) 2014-08-11 2015-08-10 Delivery of bioactive, nanoencapsulated antioxidants

Publications (2)

Publication Number Publication Date
EA201790361A1 true EA201790361A1 (ru) 2017-06-30
EA035620B1 EA035620B1 (ru) 2020-07-16

Family

ID=55304745

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201790361A EA035620B1 (ru) 2014-08-11 2015-08-10 Способы и композиция для лечения или профилактики катаракты

Country Status (12)

Country Link
US (2) US10292943B2 (ru)
EP (1) EP3179988A4 (ru)
JP (1) JP6668327B2 (ru)
KR (1) KR102218883B1 (ru)
AP (1) AP2017009684A0 (ru)
AU (1) AU2015301945B2 (ru)
BR (1) BR112017002580A2 (ru)
CA (1) CA2992879C (ru)
EA (1) EA035620B1 (ru)
MX (1) MX2017001903A (ru)
WO (1) WO2016025394A2 (ru)
ZA (1) ZA201700987B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017001903A (es) * 2014-08-11 2017-09-26 Univ Louisiana State Suministro de antioxidantes bioactivos, nanoencapsulados.
WO2019148140A2 (en) * 2018-01-26 2019-08-01 Wu Joseph C Implantable biomaterials that enhance stem cell survival and function
CA3174213A1 (en) * 2019-06-14 2020-12-17 Daniela Oana Trambitas Method for micro-encapsulation of natural ingredients by means of contacting with supercritical gas
US11298321B1 (en) 2021-07-12 2022-04-12 King Abdulaziz University Methods for treating metabolic disorder
US11253481B1 (en) 2021-07-12 2022-02-22 King Abdulaziz University Self-nanoemulsifying 3D-printed tablet composition and method of use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2011423A1 (en) * 1989-03-07 1990-09-07 Peter M. Taylor Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
US6573299B1 (en) * 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
US6703039B2 (en) 2000-12-06 2004-03-09 Bausch & Lomb Incorporated Reversible gelling system for ocular drug delivery
DE10141018A1 (de) * 2001-08-22 2003-03-13 Eth Zuerich Eidgenoessische Te Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
US20040009212A1 (en) * 2002-01-30 2004-01-15 Pharma Power Biotec Co. Ltd. Mucoadhesive thermoresponsive medicament-carrier composition
US7638137B2 (en) * 2002-06-05 2009-12-29 University Of Florida Research Foundation, Incorporated Ophthalmic drug delivery system
RU2008119234A (ru) 2005-10-16 2009-11-27 Ликорд Лтд. (Il) Композиции для лечения глазных заболеваний
WO2008137831A1 (en) 2007-05-07 2008-11-13 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Water-soluble nanoparticles containing water-insoluble compounds
KR101933024B1 (ko) * 2010-07-16 2018-12-27 유니버시다드 데 나바라 화합물의 캡슐화를 위한 나노입자, 그 제조 및 이용
MY157513A (en) * 2010-09-03 2016-06-15 Santen Sas A water-in-oil type emulsion for treating a disease of the eye
KR20140041453A (ko) * 2011-02-25 2014-04-04 사우스다코타주립대학 국소적 전달을 위한 단백질 나노 캐리어
US20120231072A1 (en) * 2011-03-11 2012-09-13 Chemisches Institut Schaefer Ag Thermo-responsive hydrogel compositions
CN103845278B (zh) 2012-11-30 2016-06-22 沈阳药科大学 一种叶黄素眼用纳米乳-温度敏感型原位凝胶及其制备方法
MX2017001903A (es) * 2014-08-11 2017-09-26 Univ Louisiana State Suministro de antioxidantes bioactivos, nanoencapsulados.

Also Published As

Publication number Publication date
WO2016025394A3 (en) 2016-05-19
EA035620B1 (ru) 2020-07-16
ZA201700987B (en) 2019-05-29
WO2016025394A2 (en) 2016-02-18
KR102218883B1 (ko) 2021-02-23
JP2017523983A (ja) 2017-08-24
US20170216221A1 (en) 2017-08-03
AU2015301945A1 (en) 2017-03-09
EP3179988A2 (en) 2017-06-21
CA2992879C (en) 2022-10-25
US10952974B2 (en) 2021-03-23
MX2017001903A (es) 2017-09-26
EP3179988A4 (en) 2018-11-14
US20190254987A1 (en) 2019-08-22
KR20170097601A (ko) 2017-08-28
CA2992879A1 (en) 2016-02-18
AU2015301945B2 (en) 2020-05-14
BR112017002580A2 (pt) 2018-03-27
JP6668327B2 (ja) 2020-03-18
AP2017009684A0 (ru) 2017-01-31
US10292943B2 (en) 2019-05-21

Similar Documents

Publication Publication Date Title
EA201790361A1 (ru) Доставка биоактивных антиоксидантов, заключенных в нанокапсулы
WO2016042163A3 (en) Ophthalmic drug compositions
PH12017500834A1 (en) Methods and formulations for treating vascular eye diseases
WO2016178586A3 (en) Collagen compositions and preparation and uses thereof
NZ729417A (en) Compositions and methods for enhancing healing and regeneration of bone and soft tissue
WO2011084366A3 (en) Compositions and drug delivery systems for intraocular delivery of sirna molecules, their use for treating conditions
SG11201912110YA (en) Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient
EP3325029A4 (en) BIOACTIVE PEPTIDES DERIVED FROM SOYBEANS FOR USE IN COMPOSITIONS AND METHODS FOR WOUND HEALING, TISSUE GENE AND REGENERATIVE MEDICINE
MX2022009155A (es) Nuevos profarmacos polimericos de la hormona del crecimiento humana (hgh).
PT3678673T (pt) Composições e processos para aministração dirigida, expressão e modulação de ácidos robonucleicos codificantes num tecido
AU2018268713A1 (en) Biopolymer compositions, scaffolds and devices
EA201891164A1 (ru) Композиции и способы получения белковых микрочастиц
EP3176163A4 (en) Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient
EA201790383A1 (ru) Композиции и способы лечения и профилактики инфекций области хирургического вмешательства
MX2019008621A (es) Peptidos terapeuticos y neuroprotectores.
IL270159B (en) Preparations containing nanometer particles for the administration of drugs for the treatment of eye diseases
EP4311575A3 (en) Methotrexate for proliferative vitreoretinopathy
MX2016009600A (es) Agentes para utilizarse en el tratamiento de la inflamacion de retina.
SG11202104178TA (en) Peptides and pharmaceutical compositions for treating eye diseases
EP3311817A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF EYES DISEASES WITH IMATINIB AS AN ACTIVE SUBSTANCE
EP3167893A4 (en) Pharmaceutical composition containing spirulina maxima extract as active ingredient for preventing and treating retinal diseases
EP3146976A4 (en) Pharmaceutical composition for preventing or treating diabetic complications and angioedema, containing natural mixture extract as active ingredient
MX2019011925A (es) Conjugados y derivados de prostaglandina para tratar el glaucoma y la hipertension ocular.
EP3651741A4 (en) COMPOSITIONS AND METHODS FOR THE TARGETED ADMINISTRATION OF THERAPEUTIC AND / OR DIAGNOSTIC SPECIES
NZ734845A (en) Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease